In this situation, the L-asparaginase was cold stored with refrigeration (7-14 days) and freezing (14 days to 6 months, one to three freeze/thaw cycles). Enzymatic activity of asparaginase was then measured, and the effects on cell proliferation and cytoxicity were evaluated on feline and canine lymphoma cells. The results of the study suggest that E.coli-derived L-asparaginase does not lose efficacy in vitro following cold storage under the above conditions. Tests demonstrated no significant differences as one to three freeze/thaw cycles were statistically similar to freshly reconstituted drug. The study did not look at the issues of extralabel use of a drug packaged for single use or concerns of sterility and patient safety when using single-dose, preservative-free solution for multiple doses in treating patients with lymphoma. [VT]
Funding: this project was partially funded by Winn Feline Foundation grant W10-049.
See also:
Simon D, Eberle N, Laacke-Singer L and Nolte I. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats. J Vet Intern Med. 2008; 22: 394-400.
LeBlanc AK, Cox SK, Kirk CA, Newman SJ, Bartges JW and Legendre AM. Effects of L-asparaginase on plasma amino acid profiles and tumor burden in cats with lymphoma. J Vet Intern Med. 2007; 21: 760-3.
Related blog articles:
Sept. 2011: Feline lymphoma therapy
Dec. 2012: Lomustine for treatment of feline lymphoma
More on cat health:
Winn Feline Foundation Library
Find us on Facebook
Follow us on Twitter